GT Biopharma
GTBP
GT Biopharma (GTBP) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.55
- EPS estimate
- −$0.68
- EPS surprise
- +19.12%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 14, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 14, 2025 | −$0.68 | −$0.55 | +19.12% | $0.00 | SEC |
| Q1 2025 | May 15, 2025 | −$0.33 | −$0.33 | +0.00% | $0.00 | SEC |
| Q4 2024 | Feb 21, 2025 | −$1.55 | −$1.67 | −7.74% | $0.00 | SEC |
| Q3 2024 | Nov 14, 2024 | −$2.70 | −$1.53 | +43.33% | $0.00 | SEC |
| Q2 2024 | Aug 14, 2024 | −$2.70 | −$2.17 | +19.63% | $0.00 | SEC |
| Q1 2024 | May 15, 2024 | −$2.70 | −$1.64 | +39.26% | $0.00 | SEC |
| Q3 2023 | Nov 1, 2023 | −$2.55 | −$1.80 | +29.41% | $0.00 | SEC |
| Q2 2023 | Aug 7, 2023 | −$3.00 | −$1.65 | +44.98% | $0.00 | SEC |
| Q1 2023 | May 15, 2023 | −$4.35 | −$0.30 | +93.10% | $0.00 | SEC |
| Q4 2022 | Mar 30, 2023 | −$5.25 | −$5.40 | −2.86% | $0.00 | SEC |
| Q3 2022 | Oct 31, 2022 | −$3.30 | −$6.60 | −100.00% | $0.00 | — |
| Q2 2022 | Aug 15, 2022 | −$5.25 | −$3.00 | +42.86% | $0.00 | — |
| Q1 2022 | May 16, 2022 | −$9.30 | −$5.10 | +45.16% | $0.00 | — |
| Q4 2021 | Mar 28, 2022 | −$5.90 | −$16.95 | −187.29% | $0.00 | — |
| Q3 2021 | Nov 10, 2021 | −$4.70 | −$5.87 | −24.99% | $0.00 | — |
| Q2 2021 | Aug 23, 2021 | −$8.30 | −$4.50 | +45.78% | $0.00 | — |
| Q1 2021 | May 17, 2021 | −$7.35 | −$54.90 | −646.94% | $0.00 | — |
| Q4 2020 | Apr 16, 2021 | −$3.45 | −$49.65 | −1339.13% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did GT Biopharma (GTBP) last report earnings?
GT Biopharma last reported on Aug 14, 2025, covering fiscal Q2 2025.
Did GTBP beat earnings estimates?
Yes. GT Biopharma reported EPS of −$0.55 for Q2 2025 against a −$0.68 estimate — a 19.12% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.